Morgan Stanley »

Maplight Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $620k 31k 20.33

More positions owned by Morgan Stanley

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)

View all positions for Morgan Stanley

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
T. Rowe Price Investment Management
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
Vanguard Group
Vanguard Capital Management
Pivotal bioVenture Partners Investment Advisor
Velan Capital Investment Management
Geode Capital Management
Siren
Vestal Point Capital

View all funds holding Maplight Therapeutics